Order Article Reprints

Hsu AY, Lin C-Y, Lin C-J, Lai C-T, Hsia N-Y, Lin J-M, Tien P-T, Meng P-P, Ku W-N, Chen W-L, et al. Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina. 2022; 58(12):1703. https://doi.org/10.3390/medicina58121703

Hsu, Alan Y., Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, and et al. 2022. "Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy" Medicina 58, no. 12: 1703. https://doi.org/10.3390/medicina58121703

Hsu, A. Y., Lin, C.-Y., Lin, C.-J., Lai, C.-T., Hsia, N.-Y., Lin, J.-M., Tien, P.-T., Meng, P.-P., Ku, W.-N., Chen, W.-L., & Tsai, Y.-Y. (2022). Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina, 58(12), 1703. https://doi.org/10.3390/medicina58121703